NCT06943885 Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
| NCT ID | NCT06943885 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Emergency Medical Center |
| Condition | Acute Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 952 participants |
| Start Date | 2025-04-25 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 952 participants in total. It began in 2025-04-25 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
While Mobile Stroke Units (MSUs) are considered as a relatively new model for acute stroke treatment, 5G Mobile Stroke Units (5G MSUs) have already come into service for stroke treatment in some parts of China. Since limited evidence has been found to suggest their advantages over conventional Emergency Medical Services (EMS), well-conducted clinical studies are required to further assess their effectiveness and safety. This study aims to evaluate whether 5G MSUs outperform standard management (SM) by EMS in terms of functional outcomes of acute ischemic stroke (AIS) patients within 4.5 hours after symptom onset in urban and rural areas of China.
Eligibility Criteria
Inclusion Criteria: 1. History and physical/neurological examination consistent with acute stroke. 2. Age≥18. 3. Last seen normal within 4hr 30 min of symptom onset. 4. Pre-stroke modified Rankin scale ≤3（Being able to ambulate）. 5. No rt-PA/TNK exclusions per guidelines, prior to CT scan or baseline labs. 6. Informed consent obtained from patient (if competent) or legal representative. Exclusion Criteria: 1. Malignant or other severe primary disease with life expectancy \<1 year. 2. Participation in other interventional randomized clinical trials within 3 months before enrollment.
Contact & Investigator
Dou Li, MD
PRINCIPAL INVESTIGATOR
Beijing Emergency Medical Center
Frequently Asked Questions
Who can join the NCT06943885 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943885 currently recruiting?
Yes, NCT06943885 is actively recruiting participants. Contact the research team at zhoujie_zj94@163.com for enrollment information.
Where is the NCT06943885 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06943885 clinical trial?
NCT06943885 is sponsored by Beijing Emergency Medical Center. The principal investigator is Dou Li, MD at Beijing Emergency Medical Center. The trial plans to enroll 952 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.